DFTX Latest Headlines

Definium's $700 Million Upsized Offering Draws Spotlight on Biotech Expansion

Market Chameleon (Wed, 24-Jun 10:33 AM)

Definium Therapeutics’ $700 Million Upsized Public Offering Highlights Strategic Push on Next-Gen Neuropsychiatric Therapies

Market Chameleon (Wed, 24-Jun 7:49 AM)

Definium Therapeutics Launches $500 Million Public Offering: Funding Psychedelic Innovation for Mental Health

Market Chameleon (Tue, 23-Jun 11:07 AM)

DFTX Draws Attention With Upcoming Phase 3 Results Webcast on Major Depressive Disorder

Market Chameleon (Mon, 22-Jun 10:31 AM)

DT120 Phase 3 Data Shows Rapid and Durable Improvement in Depression – Single Dose Achieves 8.1-Point MADRS Advantage at 6 Weeks

Market Chameleon (Mon, 22-Jun 7:07 AM)

Definium Therapeutics to Deliver Three Major Clinical Results for DT120 ODT in Next Six Months—PTSD Study to Follow in 2027

Market Chameleon (Thu, 23-Apr 7:38 AM)

Definium Therapeutics Welcomes White House Executive Order—Psychedelic Innovation at Center of Accelerated Mental Health Solutions

Market Chameleon (Mon, 20-Apr 7:06 AM)